Erythropoietin	B-protein
induces	O
tyrosine	O
phosphorylation	O
of	O
Jak2	B-protein
,	O
STAT5A	B-protein
,	O
and	O
STAT5B	B-protein
in	O
primary	B-cell_type
cultured	I-cell_type
human	I-cell_type
erythroid	I-cell_type
precursors	I-cell_type
.	O

We	O
examined	O
signaling	O
by	O
erythropoietin	B-protein
in	O
highly	B-cell_type
purified	I-cell_type
human	I-cell_type
colony	I-cell_type
forming	I-cell_type
unit-erythroid	I-cell_type
cells	I-cell_type
,	O
generated	O
in	O
vitro	O
from	O
CD34	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
cells	I-cell_type
.	O

We	O
found	O
that	O
erythropoietin	B-protein
induces	O
tyrosine	O
phosphorylation	O
of	O
Jak2	B-protein
,	O
STAT5A	B-protein
,	O
and	O
STAT5B	B-protein
.	O

Tyrosine	O
phosphorylation	O
of	O
Jak2	B-protein
reaches	O
a	O
peak	O
around	O
10	O
minutes	O
after	O
stimulation	O
and	O
is	O
maximum	O
at	O
5	O
U/mL	O
of	O
erythropoietin	B-protein
.	O

Tyrosine	O
phosphorylation	O
of	O
STAT5	B-protein
is	O
accompanied	O
by	O
the	O
translocation	O
of	O
activated	O
STAT5	B-protein
to	O
the	O
nucleus	O
as	O
shown	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
using	O
32Pi-labeled	O
STAT5	B-DNA
binding	I-DNA
site	I-DNA
in	O
the	O
beta-casein	B-DNA
promoter	I-DNA
.	O

Tyrosine	O
phosphorylation	O
STAT1	B-protein
or	O
STAT3	B-protein
was	O
not	O
detected	O
in	O
human	B-cell_type
erythroid	I-cell_type
precursors	I-cell_type
after	O
stimulation	O
with	O
erythropoietin	B-protein
.	O

Crkl	B-protein
,	O
an	O
SH2/SH3	B-protein
adapter	I-protein
protein	I-protein
,	O
becomes	O
coimmunoprecipitated	O
specifically	O
with	O
STAT5	B-protein
from	O
erythropoietin-stimulated	B-cell_type
erythroid	I-cell_type
cells	I-cell_type
;	O
although	O
it	O
was	O
shown	O
to	O
become	O
associated	O
with	O
c-Cbl	B-protein
in	O
the	O
studies	O
using	O
cell	B-cell_line
lines	I-cell_line
.	O

Thus	O
,	O
human	B-cell_type
erythroid	I-cell_type
precursors	I-cell_type
can	O
be	O
expanded	O
in	O
vitro	O
in	O
sufficient	O
numbers	O
and	O
purity	O
to	O
allow	O
its	O
usage	O
in	O
signal	O
transduction	O
studies	O
.	O

This	O
report	O
sets	O
a	O
basis	O
for	O
further	O
studies	O
on	O
signaling	O
in	O
primary	B-cell_type
cultured	I-cell_type
human	I-cell_type
erythroid	I-cell_type
precursors	I-cell_type
,	O
which	O
in	O
turn	O
contribute	O
to	O
our	O
better	O
understanding	O
in	O
the	O
differentiation	O
processes	O
of	O
erythrocytes	B-cell_type
and	O
their	O
precursors	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Erythropoietin	NULL
Induces	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
Jak2	NULL
,	NULL
STATSA	NULL
,	NULL
and	NULL
STAT5S5B	NULL
in	NULL
Primary	NULL
Cultured	NULL
Human	NULL
Erythroid	NULL
Precursors	NULL
By	NULL
Atsushi	NULL
Oda	NULL
,	NULL
Kenichi	NULL
Sawada	NULL
,	NULL
Brian	NULL
J.	NULL
Druker	NULL
,	NULL
Katsutoshi	NULL
Ozaki	NULL
,	NULL
Hina	NULL
Takano	NULL
,	NULL
Kazuki	NULL
Koizumi	NULL
,	NULL
Yoshikazu	NULL
Fukada	NULL
,	NULL
Makoto	NULL
Handa	NULL
,	NULL
Takao	NULL
Koike	NULL
,	NULL
and	NULL
Yasuo	NULL
Ikeda	NULL
We	NULL
examined	NULL
signaling	NULL
by	NULL
erythropoietin	NULL
in	NULL
highly	NULL
purified	NULL
human	NULL
colony	NULL
forming	NULL
unit-erythroid	NULL
cells	NULL
,	NULL
generated	NULL
in	NULL
vitro	NULL
from	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
erythropoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
,	NULL
STATSA	NULL
,	NULL
and	NULL
STATSB	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
reaches	NULL
a	NULL
peak	NULL
around	NULL
10	NULL
minutes	NULL
after	NULL
stimulation	NULL
and	NULL
is	NULL
maximum	NULL
at	NULL
5	NULL
U/mL	NULL
of	NULL
erythropoietin	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
is	NULL
accompanied	NULL
by	NULL
the	NULL
translocation	NULL
of	NULL
activated	NULL
STATS	NULL
to	NULL
the	NULL
nucleus	NULL
as	NULL
shown	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
using	NULL
*Â°Pi-labeled	NULL
STATS	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
B-casein	NULL
pro-moter	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
STAT1	NULL
or	NULL
STAT3	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
human	NULL
erythroid	NULL
precursors	NULL
after	NULL
stimulation	NULL
RYTHROPOIETIN	NULL
is	NULL
a	NULL
glycoprotein	NULL
hormone	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
normal	NULL
erythropoiesis	NULL
.	NULL
``	NULL

In	NULL
vitro	NULL
,	NULL
erythropoietin	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
the	NULL
survival	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
erythroid	NULL
precursors	NULL
,	NULL
although	NULL
a	NULL
recent	NULL
study	NULL
showed	NULL
that	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
and	NULL
its	NULL
soluble	NULL
form	NULL
of	NULL
the	NULL
receptor	NULL
may	NULL
also	NULL
have	NULL
a	NULL
similar	NULL
effect	NULL
on	NULL
the	NULL
erythroid	NULL
precursors	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
.	NULL
``	NULL

The	NULL
effect	NULL
of	NULL
erythropoietin	NULL
is	NULL
exerted	NULL
through	NULL
binding	NULL
to	NULL
the	NULL
specific	NULL
receptors	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
responding	NULL
cells	NULL
,	NULL
leading	NULL
to	NULL
dimerization	NULL
of	NULL
the	NULL
receptors	NULL
and	NULL
activation	NULL
of	NULL
Jak2	NULL
tyrosine	NULL
kinase	NULL
.	NULL
``	NULL

Whether	NULL
Jak2	NULL
is	NULL
preassociated	NULL
with	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
before	NULL
the	NULL
ligand	NULL
binding	NULL
or	NULL
not	NULL
is	NULL
a	NULL
controversial	NULL
issue	NULL
.	NULL
``	NULL

''	NULL
A	NULL
recent	NULL
report	NULL
suggests	NULL
that	NULL
the	NULL
association	NULL
is	NULL
a	NULL
multistep	NULL
process	NULL
,	NULL
partially	NULL
regulated	NULL
through	NULL
phosphorylation	NULL
of	NULL
the	NULL
receptor	NULL
on	NULL
tyrosine	NULL
and	NULL
serine	NULL
residues	NULL
.	NULL
``	NULL

It	NULL
was	NULL
reported	NULL
by	NULL
many	NULL
that	NULL
activation	NULL
of	NULL
Jak2	NULL
is	NULL
accompanied	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
numerous	NULL
proteins	NULL
including	NULL
Jak2	NULL
itself	NULL
,	NULL
STAT	NULL
proteins	NULL
,	NULL
Shc	NULL
,	NULL
Vav	NULL
,	NULL
and	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
,	NULL
although	NULL
tyrosine	NULL
kinases	NULL
other	NULL
than	NULL
Jak2	NULL
may	NULL
also	NULL
phosphorylate	NULL
these	NULL
Colony-forming	NULL
unit-erythroid	NULL
(	NULL
CFU-E	NULL
)	NULL
comprises	NULL
only	NULL
0.5	NULL
%	NULL
or	NULL
less	NULL
of	NULL
all	NULL
cells	NULL
in	NULL
normal	NULL
bone	NULL
marrow	NULL
.	NULL
``	NULL

Accordingly	NULL
,	NULL
most	NULL
of	NULL
the	NULL
studies	NULL
cited	NULL
above	NULL
have	NULL
used	NULL
murine	NULL
factor-dependent	NULL
cell	NULL
lines	NULL
genetically	NULL
engineered	NULL
to	NULL
express	NULL
erythropoietin	NULL
receptors	NULL
or	NULL
murine	NULL
and	NULL
human	NULL
leukemic	NULL
cell	NULL
lines	NULL
responding	NULL
to	NULL
erythropoietin	NULL
.	NULL

Although	NULL
such	NULL
cells	NULL
would	NULL
undergo	NULL
differentiation	NULL
in	NULL
response	NULL
to	NULL
erythropoietin	NULL
,	NULL
the	NULL
signaling	NULL
processes	NULL
in	NULL
them	NULL
could	NULL
be	NULL
affected	NULL
by	NULL
cellular	NULL
transformation	NULL
.	NULL

A	NULL
few	NULL
studies	NULL
have	NULL
used	NULL
primary	NULL
erythroid	NULL
cells	NULL
from	NULL
rodents	NULL
or	NULL
We	NULL
show	NULL
here	NULL
that	NULL
purified	NULL
erythroid	NULL
progenitors	NULL
can	NULL
be	NULL
expanded	NULL
from	NULL
CD34*	NULL
cells	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
in	NULL
sufficient	NULL
numbers	NULL
to	NULL
allow	NULL
the	NULL
examination	NULL
of	NULL
early	NULL
signaling	NULL
by	NULL
erythropoietin	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

-	NULL
HEPES	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
2-mercaptoctha-nol	NULL
(	NULL
2-ME	NULL
)	NULL
,	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
,	NULL
DNase	NULL
,	NULL
chicken	NULL
egg	NULL
albumin	NULL
,	NULL
Iscove	NULL
's	NULL
Modified	NULL
Dulbecco	NULL
's	NULL
Medium	NULL
(	NULL
IMDM	NULL
)	NULL
,	NULL
propidium	NULL
iodide	NULL
(	NULL
Pl	NULL
)	NULL
,	NULL
protein	NULL
A-Sepharose	NULL
,	NULL
protein	NULL
G-Sephalose	NULL
,	NULL
isopropyl	NULL
B-D-thiogalactopyranoside	NULL
(	NULL
IPTG	NULL
)	NULL
,	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
Tris	NULL
(	NULL
hydroxymethyl	NULL
)	NULL
aminomethane	NULL
(	NULL
Tris	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Polyvinylidene	NULL
difluoride	NULL
(	NULL
PVDF	NULL
)	NULL
mem	NULL
Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
2	NULL
(	NULL
July	NULL
15	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
443-451	NULL
with	NULL
erythropoietin	NULL
.	NULL

Crkl	NULL
,	NULL
an	NULL
SH2/SH3	NULL
adapter	NULL
protein	NULL
,	NULL
becomes	NULL
coimmunoprecipitated	NULL
specifically	NULL
with	NULL
STATS	NULL
from	NULL
erythropoietin-stimulated	NULL
erythroid	NULL
cells	NULL
;	NULL
although	NULL
it	NULL
was	NULL
show	NULL
n	NULL
to	NULL
become	NULL
associated	NULL
with	NULL
c-Cbl	NULL
in	NULL
the	NULL
studies	NULL
using	NULL
cell	NULL
lines	NULL
.	NULL

Thus	NULL
,	NULL
human	NULL
erythroid	NULL
precursors	NULL
can	NULL
be	NULL
expanded	NULL
in	NULL
vitro	NULL
in	NULL
sufficient	NULL
numbers	NULL
and	NULL
purity	NULL
to	NULL
allow	NULL
its	NULL
usage	NULL
in	NULL
signal	NULL
transduction	NULL
studies	NULL
.	NULL

This	NULL
report	NULL
sets	NULL
a	NULL
basis	NULL
for	NULL
further	NULL
studies	NULL
on	NULL
signaling	NULL
in	NULL
primary	NULL
cultured	NULL
human	NULL
erythroid	NULL
precursors	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
contribute	NULL
to	NULL
our	NULL
better	NULL
understanding	NULL
in	NULL
the	NULL
differentiation	NULL
processes	NULL
of	NULL
erythrocytes	NULL
and	NULL
their	NULL
precursors	NULL
.	NULL

Â©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

branes	NULL
(	NULL
pore	NULL
size	NULL
,	NULL
0.45	NULL
um	NULL
)	NULL
were	NULL
from	NULL
Millipore	NULL
Corporation	NULL
(	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
molecular	NULL
standards	NULL
and	NULL
*Â°Pi	NULL
were	NULL
from	NULL
Amersham	NULL
(	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
or	NULL
BioRad	NULL
(	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Double	NULL
stranded	NULL
Poly	NULL
(	NULL
dI-dC	NULL
)	NULL
was	NULL
from	NULL
Pharmacia	NULL
Biotech	NULL
(	NULL
Milwaukee	NULL
,	NULL
WD	NULL
.	NULL

Enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
reagents	NULL
including	NULL
secondary	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
.	NULL

Insulin	NULL
(	NULL
porcine	NULL
sodium	NULL
,	NULL
activity	NULL
United	NULL
States	NULL
Pharmacopoeia	NULL
[	NULL
USP	NULL
]	NULL
U/mg	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
and	NULL
Behring	NULL
Diagnostics	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Antiphosphotyrosine	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
was	NULL
used	NULL
as	NULL
described	NULL
.	NULL
``	NULL

STAT3	NULL
,	NULL
Crkl	NULL
and	NULL
Jak2	NULL
antisera	NULL
,	NULL
and	NULL
anti-STAT1	NULL
and	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

An	NULL
anti-STATS5	NULL
monoclonal	NULL
antibody	NULL
was	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

Nitroblue	NULL
tetrazolium	NULL
chloride	NULL
(	NULL
NBT	NULL
)	NULL
and	NULL
5-bromo-4	NULL
chloro-3-indolyl	NULL
phosphate	NULL
p-toluidine	NULL
salt	NULL
(	NULL
BCIP	NULL
)	NULL
were	NULL
from	NULL
GIBCO	NULL
BRL	NULL
(	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

For	NULL
EMSA	NULL
,	NULL
an	NULL
anti-STATS5	NULL
antiserum	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr	NULL
Hiroshi	NULL
Wakao	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
described	NULL
previously	NULL
,	NULL
was	NULL
used	NULL
.	NULL
``	NULL

''	NULL
STATSA	NULL
and	NULL
STATSB	NULL
antisera	NULL
were	NULL
from	NULL
R	NULL
&	NULL
D	NULL
systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Recombinant	NULL
erythropoietin	NULL
,	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Keio	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
the	NULL
Blood	NULL
Center	NULL
,	NULL
Keio	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
;	NULL
The	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
II	NULL
,	NULL
Hokkaido	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
Sapporo	NULL
,	NULL
Hokkaido	NULL
060	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
and	NULL
Medical	NULL
Oncology	NULL
,	NULL
Oregon	NULL
Health	NULL
Sciences	NULL
University	NULL
,	NULL
Portland	NULL
,	NULL
OR	NULL
.	NULL

Submitted	NULL
October	NULL
3	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
March	NULL
13	NULL
,	NULL
1998	NULL
.	NULL

A.O0	NULL
.	NULL

and	NULL
K.S	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
in	NULL
aid	NULL
from	NULL
The	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
Sports	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
(	NULL
A.0	NULL
.	NULL

,	NULL
K.S	NULL
.	NULL

,	NULL
and	NULL
YL	NULL
.	NULL
)	NULL

,	NULL
a	NULL
research	NULL
grant	NULL
for	NULL
Idiopathic	NULL
Disorders	NULL
of	NULL
Hematopoietic	NULL
Organs	NULL
Research	NULL
Committee	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Health	NULL
and	NULL
Welfare	NULL
of	NULL
Japan	NULL
(	NULL
K.S	NULL
.	NULL
)	NULL

,	NULL
the	NULL
Ryoichi	NULL
Naito	NULL
Foundation	NULL
for	NULL
Medical	NULL
Research	NULL
(	NULL
A.0	NULL
.	NULL
)	NULL

,	NULL
a	NULL
research	NULL
grant	NULL
for	NULL
the	NULL
Development	NULL
of	NULL
Advanced	NULL
Therapeutics	NULL
from	NULL
Hokkaido	NULL
University	NULL
School	NULL
of	NULL
medicine	NULL
and	NULL
the	NULL
Sankyo	NULL
Life	NULL
Science	NULL
Foundation	NULL
(	NULL
K.S	NULL
.	NULL
)	NULL

,	NULL
and	NULL
research	NULL
grants	NULL
for	NULL
Life	NULL
Sciences	NULL
and	NULL
Medicine	NULL
,	NULL
Keio	NULL
University	NULL
Medical	NULL
Science	NULL
Fund	NULL
(	NULL
A.0	NULL
.	NULL
)	NULL

.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Atsushi	NULL
Oda	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Keio	NULL
University	NULL
,	NULL
35	NULL
Shinanoma-chi	NULL
,	NULL
Tokyo	NULL
160	NULL
,	NULL
Japan	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9202-0025	NULL
$	NULL
3.00/0	NULL
443	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

444	NULL
IL-6	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
and	NULL
SCF	NULL
were	NULL
kindly	NULL
donated	NULL
from	NULL
Kirin	NULL
Brewery	NULL
Co	NULL
Ltd	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Erythropoietin	NULL
was	NULL
also	NULL
kindly	NULL
donated	NULL
from	NULL
Chugai	NULL
Pharmaceutical	NULL
Co	NULL
Ltd	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Vitamin	NULL
B	NULL
12	NULL
and	NULL
folic	NULL
acid	NULL
were	NULL
from	NULL
Sankyo	NULL
Pharmaceutical	NULL
Co	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
Takeda	NULL
Pharmaceutical	NULL
Co	NULL
(	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Human	NULL
IL-3	NULL
(	NULL
10Â°	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
U/mg	NULL
)	NULL
was	NULL
from	NULL
Amgen	NULL
Biologicals	NULL
(	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Dynabeads	NULL
M	NULL
450	NULL
coated	NULL
with	NULL
goat	NULL
antimouse	NULL
IgG	NULL
were	NULL
from	NULL
Dynal	NULL
Inc	NULL
(	NULL
Great	NULL
Neck	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
were	NULL
from	NULL
Flow	NULL
Laboratories	NULL
Inc	NULL
(	NULL
McLean	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Ex	NULL
vivo	NULL
generation	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

Recombinant	NULL
human	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
;	NULL
Chugai	NULL
Pharmaceutical	NULL
Co	NULL
and	NULL
Kyohwa	NULL
Hakkoh	NULL
Pharmaceutical	NULL
Co	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
was	NULL
administered	NULL
to	NULL
healthy	NULL
adult	NULL
volunteers	NULL
(	NULL
who	NULL
had	NULL
previously	NULL
signed	NULL
consent	NULL
forms	NULL
approved	NULL
by	NULL
the	NULL
Hokkaido	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
and	NULL
the	NULL
Hokkaido	NULL
Red	NULL
Cross	NULL
Blood	NULL
Center	NULL
Committee	NULL
for	NULL
the	NULL
Protection	NULL
of	NULL
Human	NULL
Subjects	NULL
)	NULL
,	NULL
as	NULL
described	NULL
elsewhere	NULL
.	NULL
``	NULL

''	NULL
The	NULL
mobilized	NULL
peripheral	NULL
blood	NULL
(	NULL
PB	NULL
)	NULL
CD34	NULL
*	NULL
cells	NULL
were	NULL
isolated	NULL
with	NULL
immunomag-netic	NULL
beads	NULL
,	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
.	NULL
``	NULL

''	NULL
The	NULL
cells	NULL
were	NULL
then	NULL
cryopreserved	NULL
and	NULL
stored	NULL
until	NULL
use	NULL
in	NULL
a	NULL
tank	NULL
with	NULL
liquid	NULL
nitrogen	NULL
.	NULL

The	NULL
frozen	NULL
PB	NULL
CD34*	NULL
cells	NULL
were	NULL
thawed	NULL
,	NULL
suspended	NULL
in	NULL
IMDM	NULL
containing	NULL
30	NULL
%	NULL
heat	NULL
inactivated	NULL
and	NULL
100	NULL
U/mL	NULL
DNase	NULL
,	NULL
and	NULL
were	NULL
centrifuged	NULL
at	NULL
400g	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
two	NULL
times	NULL
with	NULL
IMDM	NULL
containing	NULL
20	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
IMDM	NULL
containing	NULL
0.3	NULL
%	NULL
deionized	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
liquid	NULL
phase	NULL
,	NULL
as	NULL
described	NULL
elsewhere	NULL
with	NULL
minor	NULL
modifica-tion	NULL
.	NULL
``	NULL

''	NULL
In	NULL
brief	NULL
,	NULL
the	NULL
cells	NULL
ranging	NULL
from	NULL
0.5	NULL
X	NULL
10	NULL
%	NULL
to	NULL
2.0	NULL
X	NULL
10+	NULL
cells/mL	NULL
were	NULL
suspended	NULL
in	NULL
a	NULL
mixture	NULL
containing	NULL
20	NULL
%	NULL
FCS	NULL
,	NULL
10	NULL
%	NULL
heat-inactivated	NULL
pooled	NULL
human	NULL
AB	NULL
serum	NULL
,	NULL
1	NULL
%	NULL
BSA	NULL
,	NULL
10	NULL
ug/mL	NULL
insulin	NULL
,	NULL
vitamin	NULL
B	NULL
12	NULL
at	NULL
10	NULL
ug/mL	NULL
,	NULL
and	NULL
folic	NULL
acid	NULL
at	NULL
15	NULL
ug/mL	NULL
,	NULL
with	NULL
recombinant	NULL
human	NULL
IL-3	NULL
at	NULL
100	NULL
U/mL	NULL
,	NULL
recombinant	NULL
human	NULL
SCF	NULL
at	NULL
100	NULL
ng/mL	NULL
,	NULL
and	NULL
erythropoietin	NULL
(	NULL
180,000	NULL
U/mg	NULL
)	NULL
at	NULL
4	NULL
U/mL	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
X	NULL
10~5	NULL
mol/mL	NULL
2-ME	NULL
,	NULL
penicillin	NULL
at	NULL
50	NULL
U/mL	NULL
and	NULL
streptomycin	NULL
at	NULL
50	NULL
U/mL	NULL
,	NULL
and	NULL
IMDM	NULL
in	NULL
a	NULL
50	NULL
mL	NULL
polystyrene	NULL
flask	NULL
(	NULL
Corning	NULL
Costar	NULL
Corp	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
8	NULL
days	NULL
at	NULL
37Â°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
/95	NULL
%	NULL
atmosphere	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
IMDM	NULL
containing	NULL
0.3	NULL
%	NULL
BSA	NULL
,	NULL
and	NULL
were	NULL
factor	NULL
starved	NULL
in	NULL
IMDM	NULL
containing	NULL
20	NULL
%	NULL
FCS	NULL
for	NULL
12	NULL
hours	NULL
(	NULL
day-8	NULL
cells	NULL
)	NULL
.	NULL
``	NULL

Semisolid	NULL
culture	NULL
of	NULL
progenitors	NULL
.	NULL

Day-8	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
triplicate	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
500	NULL
cells/mL	NULL
in	NULL
flat-bottomed	NULL
,	NULL
48-well	NULL
,	NULL
tissue	NULL
culture	NULL
plates	NULL
(	NULL
Linbro	NULL
,	NULL
Flow	NULL
Laboratories	NULL
)	NULL
with	NULL
0.25	NULL
mL	NULL
serum-free	NULL
fibrin	NULL
clots	NULL
,	NULL
as	NULL
described	NULL
with	NULL
erythropoietin	NULL
at	NULL
2	NULL
U/mL	NULL
with	NULL
or	NULL
without	NULL
SCF	NULL
at	NULL
100	NULL
ng/mL	NULL
and	NULL
IL-3	NULL
at	NULL
100	NULL
U/mL	NULL
.	NULL
``	NULL

After	NULL
7	NULL
days	NULL
of	NULL
incubation	NULL
at	NULL
37Â°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
/95	NULL
%	NULL
atmosphere	NULL
,	NULL
the	NULL
clots	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
with	NULL
benzidine-hematoxylin	NULL
.	NULL
``	NULL

''	NULL
Erythroid	NULL
colony	NULL
forming	NULL
cells	NULL
(	NULL
ECFC	NULL
)	NULL
were	NULL
defined	NULL
as	NULL
cells	NULL
that	NULL
gave	NULL
rise	NULL
to	NULL
colonies	NULL
of	NULL
2	NULL
to	NULL
49	NULL
hemoglobinized	NULL
cells	NULL
after	NULL
7	NULL
days	NULL
of	NULL
culture	NULL
of	NULL
day-8	NULL
cells	NULL
.	NULL
``	NULL

Flow	NULL
cytometry	NULL
.	NULL

-	NULL
Phenotyping	NULL
of	NULL
the	NULL
purified	NULL
cells	NULL
and	NULL
day-8	NULL
cells	NULL
was	NULL
analyzed	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
vantage	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
run	NULL
by	NULL
Lysis	NULL
II	NULL
,	NULL
as	NULL
reported	NULL
previ-ously	NULL
.	NULL
``	NULL

''	NULL
In	NULL
brief	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
staining	NULL
medium	NULL
(	NULL
SM	NULL
;	NULL
phosphate	NULL
buffered	NULL
saline	NULL
[	NULL
PBS	NULL
]	NULL
supplemented	NULL
with	NULL
0.05	NULL
%	NULL
NaN	NULL
:	NULL
and	NULL
3	NULL
%	NULL
FCS	NULL
)	NULL
.	NULL

After	NULL
counting	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
,	NULL
1	NULL
X	NULL
105	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
HPCA-2	NULL
(	NULL
8G12	NULL
,	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
[	NULL
FITC	NULL
]	NULL
or	NULL
phycoerythrin-conjugated	NULL
[	NULL
PE	NULL
]	NULL
,	NULL
Becton	NULL
Dickinson	NULL
)	NULL
,	NULL
glycopho-rin	NULL
A	NULL
(	NULL
Gly	NULL
A	NULL
FITC	NULL
;	NULL
DAKO	NULL
Japan	NULL
Co	NULL
,	NULL
Kyoto	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
My7	NULL
(	NULL
CD13	NULL
PE	NULL
;	NULL
Coulter	NULL
Immunology	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
,	NULL
and	NULL
CD117	NULL
(	NULL
c-kit	NULL
PE	NULL
;	NULL
Immunotech	NULL
,	NULL
Marseilles	NULL
,	NULL
France	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
SM	NULL
twice	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
mL	NULL
of	NULL
SM	NULL
containing	NULL
5	NULL
ug/mL	NULL
of	NULL
PI	NULL
.	NULL

Cell	NULL
aggregates	NULL
and	NULL
dead	NULL
cells	NULL
were	NULL
excluded	NULL
using	NULL
forward	NULL
and	NULL
side	NULL
scatter	NULL
and	NULL
PI	NULL
staining	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
10,000	NULL
events	NULL
were	NULL
analyzed	NULL
.	NULL

Immunoprecipitation	NULL
,	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
Western	NULL
blotting	NULL
.	NULL

After	NULL
starvation	NULL
,	NULL
day-8	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
erythropoietin	NULL
.	NULL

Cells	NULL
ODA	NULL
ET	NULL
AL	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
15	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
10	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
0.8	NULL
ug/mL	NULL
leupeptin	NULL
,	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
(	NULL
vol/wt	NULL
)	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

After	NULL
20	NULL
minutes	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
10,0008	NULL
(	NULL
at	NULL
4Â°C	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
removed	NULL
and	NULL
precleared	NULL
with	NULL
preimmune	NULL
serum	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
or	NULL
protein	NULL
G-Sephalose	NULL
(	NULL
40	NULL
uL	NULL
of	NULL
50	NULL
%	NULL
slurry	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

Antisera	NULL
were	NULL
then	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
to	NULL
3	NULL
hours	NULL
on	NULL
ice	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
(	NULL
40	NULL
uL	NULL
of	NULL
50	NULL
%	NULL
slurry	NULL
)	NULL
was	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
with	NULL
1	NULL
mL	NULL
of	NULL
cold	NULL
washing	NULL
buffer	NULL
(	NULL
15	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
10	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
1	NULL
mmol/L	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
0.8	NULL
ug/mL	NULL
leupeptin	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
(	NULL
vol/wt	NULL
)	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
three	NULL
times	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
Laemmli	NULL
's	NULL
sample	NULL
buffer	NULL
(	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
5	NULL
%	NULL
2-ME	NULL
,	NULL
50	NULL
mmol/L	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
``	NULL
Â°	NULL
and	NULL
0.002	NULL
%	NULL
bromophenol	NULL
blue	NULL
)	NULL
,	NULL
``	NULL
with	NULL
10	NULL
mmol/L	NULL
EGTA	NULL
and	NULL
1	NULL
mmol/L	NULL
sodium	NULL
orthovanadate	NULL
.	NULL

After	NULL
boiling	NULL
at	NULL
95Â°C	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
one-dimensional	NULL
electrophoresis	NULL
was	NULL
performed	NULL
on	NULL
SDS	NULL
10	NULL
%	NULL
or	NULL
7.5	NULL
to	NULL
15	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
as	NULL
described	NULL
.	NULL
``	NULL

''	NULL
Separated	NULL
proteins	NULL
were	NULL
electrophoretically	NULL
transferred	NULL
from	NULL
the	NULL
gel	NULL
onto	NULL
PVDF	NULL
membranes	NULL
or	NULL
nitrocellulose	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
Tris	NULL
(	NULL
25	NULL
mmol/L	NULL
)	NULL
,	NULL
glycine	NULL
(	NULL
192	NULL
mmol/L	NULL
)	NULL
and	NULL
20	NULL
%	NULL
methanol	NULL
at	NULL
0.2	NULL
amps	NULL
for	NULL
12	NULL
hours	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

To	NULL
block	NULL
residual	NULL
protein	NULL
binding	NULL
sites	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
in	NULL
TBST	NULL
(	NULL
Tris-buffered	NULL
saline	NULL
[	NULL
TBS	NULL
]	NULL
;	NULL
10	NULL
mmol/L	NULL
Tris	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
pH	NULL
7.6	NULL
with	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
with	NULL
10	NULL
%	NULL
chicken	NULL
egg	NULL
albumin	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
with	NULL
TBST	NULL
and	NULL
incubated	NULL
overnight	NULL
with	NULL
primary	NULL
antibodies	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1.0	NULL
pg/mL	NULL
in	NULL
TBST	NULL
.	NULL

The	NULL
primary	NULL
antibody	NULL
was	NULL
removed	NULL
and	NULL
the	NULL
blots	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
TBST	NULL
and	NULL
incubated	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
or	NULL
alkaline	NULL
phosphatase-conjugated	NULL
second	NULL
antibodies	NULL
diluted	NULL
1:3000	NULL
in	NULL
TBST	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
TBST	NULL
.	NULL

Antibody	NULL
reactions	NULL
were	NULL
detected	NULL
with	NULL
NBT/BCIP	NULL
or	NULL
chemiluminescence	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

EMSA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
40	NULL
uL	NULL
,	NULL
containing	NULL
10	NULL
to	NULL
20	NULL
ug	NULL
protein	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
day-8	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
by	NULL
lysis	NULL
followed	NULL
by	NULL
high	NULL
salt	NULL
extraction	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Two	NULL
microliters	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
mixed	NULL
with	NULL
20	NULL
uL	NULL
of	NULL
binding	NULL
buffer	NULL
[	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
1,4	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
%	NULL
NP-40	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mg/mL	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
2	NULL
mg/mL	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
pH	NULL
7.5	NULL
]	NULL
containing	NULL
50,000	NULL
cpm	NULL
end-labeled	NULL
bovine	NULL
B-casein	NULL
promoter	NULL
probe	NULL
(	NULL
5'-AGATTCTAGGAATTCAAATC-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Complexes	NULL
were	NULL
separated	NULL
on	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.25	NULL
X	NULL
Tris	NULL
borate	NULL
EDTA	NULL
buffer	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

TF-1	NULL
cell	NULL
.	NULL

-	NULL
Human	NULL
IL-3	NULL
and	NULL
GM-CSF-dependent	NULL
TF-1	NULL
cell	NULL
line	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Hisamaru	NULL
Hirai	NULL
(	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
IMDM	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
and	NULL
1	NULL
ng/mL	NULL
human	NULL
GM-CSF	NULL
.	NULL

Before	NULL
stimulation	NULL
with	NULL
GM-CSF	NULL
or	NULL
IL-3	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
IMDM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
without	NULL
exogenous	NULL
IL-3	NULL
or	NULL
GM-CSF	NULL
for	NULL
18	NULL
hours	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
,	NULL
they	NULL
were	NULL
incubated	NULL
in	NULL
PBS	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
at	NULL
37Â°C	NULL
.	NULL

GST	NULL
binding	NULL
assays	NULL
.	NULL

-	NULL
The	NULL
GST-SH2	NULL
domain	NULL
of	NULL
Crk	NULL
]	NULL
fusion	NULL
protein	NULL
(	NULL
GST-Crkl-SH2	NULL
)	NULL
was	NULL
generated	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

``	NULL
``	NULL
>	NULL
*	NULL
The	NULL
GST-fusion	NULL
construct	NULL
was	NULL
transformed	NULL
into	NULL
Escherichia	NULL
coli	NULL
DH-5	NULL
Â«	NULL
and	NULL
protein	NULL
expression	NULL
was	NULL
induced	NULL
by	NULL
0.5	NULL
mmol/L	NULL
IPTG	NULL
to	NULL
exponentially	NULL
growing	NULL
cells	NULL
.	NULL

The	NULL
GST-Crkl-SH2	NULL
was	NULL
isolated	NULL
from	NULL
sonicated	NULL
bacterial	NULL
lysates	NULL
using	NULL
glutathione	NULL
sepharose	NULL
beads	NULL
.	NULL

A	NULL
total	NULL
of	NULL
2.5	NULL
ug	NULL
of	NULL
GST-fusion	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
50	NULL
uL	NULL
of	NULL
glutathione	NULL
sepharose	NULL
beads	NULL
in	NULL
bacterial	NULL
lysis	NULL
buffer	NULL
(	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
16	NULL
mmol/L	NULL
Na	NULL
;	NULL
HPO	NULL
,	NULL
,	NULL
4	NULL
mmol/L	NULL
NaH	NULL
;	NULL
PO4	NULL
,	NULL
[	NULL
pH	NULL
7.3	NULL
]	NULL
containing	NULL
10	NULL
ug	NULL
of	NULL
aprotinin	NULL
,	NULL
1	NULL
mmol/L	NULL
orthovanadate	NULL
,	NULL
1	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
B-mercaptoctha-nol	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
and	NULL
were	NULL
incubated	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SIGNALING	NULL
IN	NULL
HUMAN	NULL
ERYTHROID	NULL
CELLS	NULL
with	NULL
cell	NULL
lysates	NULL
for	NULL
3	NULL
hours	NULL
on	NULL
ice	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
for	NULL
immunoblot	NULL
analysis	NULL
.	NULL

RESULTS	NULL
The	NULL
purified	NULL
fraction	NULL
from	NULL
mobilized	NULL
PB	NULL
contained	NULL
96.7	NULL
%	NULL
*	NULL
1.6	NULL
%	NULL
(	NULL
n	NULL
=	NULL
3	NULL
,	NULL
mean	NULL
+	NULL
SD	NULL
)	NULL
CD34*	NULL
cells	NULL
.	NULL

Cultivation	NULL
of	NULL
PB	NULL
CD34*	NULL
cells	NULL
for	NULL
8	NULL
days	NULL
in	NULL
serum-containing	NULL
medium	NULL
with	NULL
erythropoietin	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
SCF	NULL
resulted	NULL
in	NULL
a	NULL
120	NULL
+	NULL
49-fold	NULL
expansion	NULL
of	NULL
the	NULL
total	NULL
cell	NULL
number	NULL
(	NULL
day-8	NULL
cells	NULL
,	NULL
n	NULL
=	NULL
8	NULL
)	NULL
with	NULL
a	NULL
viability	NULL
of	NULL
96	NULL
%	NULL
+	NULL
3	NULL
%	NULL
.	NULL

A	NULL
total	NULL
of	NULL
71	NULL
%	NULL
+	NULL
13	NULL
%	NULL
cells	NULL
expressed	NULL
the	NULL
specific	NULL
erythroid	NULL
marker	NULL
Gly	NULL
A	NULL
,	NULL
whereas	NULL
CD34	NULL
and	NULL
myelomonocytic	NULL
marker	NULL
CD13	NULL
were	NULL
almost	NULL
absent	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

In	NULL
morphologic	NULL
analysis	NULL
by	NULL
May-Grunwald-Giemsa	NULL
staining	NULL
,	NULL
day-8	NULL
cells	NULL
predominantly	NULL
consisted	NULL
of	NULL
immature	NULL
erythroid	NULL
cells	NULL
with	NULL
a	NULL
purity	NULL
of	NULL
92	NULL
%	NULL
+	NULL
6	NULL
%	NULL
,	NULL
*	NULL
``	NULL
whereas	NULL
most	NULL
of	NULL
the	NULL
remaining	NULL
cells	NULL
showed	NULL
a	NULL
basophilic/eosinophilic-like	NULL
fea-ture	NULL
.	NULL

The	NULL
maturation	NULL
level	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
closely	NULL
associates	NULL
with	NULL
colony	NULL
stimulating	NULL
factor	NULL
(	NULL
CSF	NULL
)	NULL
requirements	NULL
for	NULL
erythroid	NULL
development	NULL
.	NULL

*	NULL
When	NULL
CSF	NULL
requirements	NULL
of	NULL
day-8	NULL
cells	NULL
were	NULL
analyzed	NULL
in	NULL
serum-free	NULL
medium	NULL
,	NULL
the	NULL
ECFC	NULL
required	NULL
erythropoietin	NULL
alone	NULL
but	NULL
not	NULL
IL-3	NULL
and	NULL
SCF	NULL
for	NULL
erythroid	NULL
development	NULL
,	NULL
which	NULL
indicates	NULL
that	NULL
ECFC	NULL
in	NULL
day-8	NULL
cells	NULL
predominantly	NULL
consists	NULL
of	NULL
mature	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

The	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
that	NULL
gave	NULL
rise	NULL
to	NULL
aggregates	NULL
with	NULL
8	NULL
to	NULL
49	NULL
erythroblasts	NULL
and	NULL
that	NULL
were	NULL
equivalent	NULL
to	NULL
CFU-E	NULL
,	NULL
consisted	NULL
78.8	NULL
%	NULL
+	NULL
2.5	NULL
%	NULL
,	NULL
whereas	NULL
the	NULL
rest	NULL
of	NULL
ECFC	NULL
gave	NULL
rise	NULL
to	NULL
aggregates	NULL
with	NULL
2	NULL
to	NULL
7	NULL
erythroblasts	NULL
.	NULL

We	NULL
then	NULL
set	NULL
out	NULL
to	NULL
examine	NULL
some	NULL
early	NULL
signaling	NULL
events	NULL
in	NULL
these	NULL
human	NULL
erythroid	NULL
precursor	NULL
cells	NULL
.	NULL

When	NULL
Jak2	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
lysates	NULL
of	NULL
erythroid	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
stimulation	NULL
with	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
,	NULL
we	NULL
saw	NULL
the	NULL
induc-ible	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
(	NULL
Fig	NULL
1A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Jak2	NULL
was	NULL
equally	NULL
immunoprecipitated	NULL
before	NULL
and	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
1A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
experiments	NULL
of	NULL
Jak2	NULL
tyrosine	NULL
phosphorylation	NULL
showed	NULL
tyrosine	NULL
phosphorylation	NULL
within	NULL
1	NULL
minute	NULL
that	NULL
reached	NULL
a	NULL
peak	NULL
within	NULL
approximately	NULL
10	NULL
minutes	NULL
after	NULL
addition	NULL
of	NULL
erythropoietin	NULL
and	NULL
then	NULL
decreased	NULL
(	NULL
10	NULL
U/mL	NULL
;	NULL
Fig	NULL
1B	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Erythropoietin	NULL
induced	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
erythroid	NULL
cells	NULL
in	NULL
a	NULL
dose-dependent	NULL
Table	NULL
1	NULL
.	NULL

Characterization	NULL
of	NULL
Expanded	NULL
Cells	NULL
119.9-fold	NULL
+	NULL
48.6-fold	NULL
96.4	NULL
%	NULL
+	NULL
2.7	NULL
%	NULL
91.4	NULL
%	NULL
+	NULL
5.9	NULL
%	NULL
Expansion	NULL
rate	NULL
Viability	NULL
Purity	NULL
of	NULL
erythroid	NULL
cells	NULL
Purity	NULL
of	NULL
ECFC	NULL
CSF	NULL
combination	NULL
EP	NULL
40.5	NULL
%	NULL
+	NULL
4.3	NULL
%	NULL
EP	NULL
+	NULL
IL-3	NULL
41.1	NULL
%	NULL
+	NULL
3.3	NULL
%	NULL
EP	NULL
+	NULL
IL-3	NULL
+	NULL
SCF	NULL
42.5	NULL
%	NULL
+	NULL
4.0	NULL
%	NULL
Surface	NULL
Marker	NULL
Gly	NULL
A	NULL
79.5	NULL
%	NULL
+	NULL
61	NULL
%	NULL
cos4	NULL
2.6	NULL
%	NULL
+	NULL
1.0	NULL
%	NULL
CD117	NULL
33.0	NULL
%	NULL
+	NULL
15.6	NULL
%	NULL
Cois	NULL
3.7	NULL
%	NULL
+	NULL
11	NULL
%	NULL
Values	NULL
are	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
of	NULL
eight	NULL
independent	NULL
experi-ments	NULL
.	NULL

Abbreviations	NULL
:	NULL
ECFC	NULL
,	NULL
erythroid	NULL
colony-forming	NULL
cells	NULL
;	NULL
CSF	NULL
,	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
EP	NULL
,	NULL
erythropoietin	NULL
;	NULL
IL-3	NULL
,	NULL
interleukin-3	NULL
;	NULL
SCF	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
.	NULL

445	NULL
manner	NULL
(	NULL
0.5	NULL
to	NULL
5	NULL
U/mL	NULL
;	NULL
Fig	NULL
1C	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
STAT5A	NULL
and	NULL
B	NULL
become	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
erythroid	NULL
cells	NULL
stimulated	NULL
with	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
,	NULL
for	NULL
10	NULL
minutes	NULL
)	NULL
.	NULL

A	NULL
STATS	NULL
monoclonal	NULL
antibody	NULL
recognizes	NULL
both	NULL
STAT	NULL
5A	NULL
and	NULL
STAT5B	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
moved	NULL
faster	NULL
than	NULL
STAT5A	NULL
in	NULL
the	NULL
gel	NULL
.	NULL

Both	NULL
STATSA	NULL
and	NULL
STATS5B	NULL
became	NULL
tyrosine	NULL
phosphorylated	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
thin	NULL
tyrosine	NULL
phosphorylated	NULL
band	NULL
,	NULL
which	NULL
moved	NULL
slower	NULL
than	NULL
STAT5B	NULL
,	NULL
may	NULL
be	NULL
STAT5A	NULL
,	NULL
because	NULL
STATS5B	NULL
antisera	NULL
are	NULL
weakly	NULL
cross	NULL
reactive	NULL
with	NULL
STAT5A	NULL
according	NULL
to	NULL
the	NULL
manufac-turers	NULL
'	NULL
instructions	NULL
.	NULL

After	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
STATS	NULL
dimerizes	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
it	NULL
activates	NULL
or	NULL
represses	NULL
transcription	NULL
.	NULL
``	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
treatment	NULL
of	NULL
the	NULL
erythroid	NULL
cells	NULL
with	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
,	NULL
for	NULL
20	NULL
minutes	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
STATS	NULL
to	NULL
a	NULL
phosphorylated	NULL
probe	NULL
from	NULL
the	NULL
B-casein	NULL
promoter	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
erythroid	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
stimulation	NULL
with	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
,	NULL
for	NULL
20	NULL
minutes	NULL
)	NULL
.	NULL

Erythropoietin	NULL
induced	NULL
the	NULL
electrophoretic	NULL
shift	NULL
of	NULL
the	NULL
end-labeled	NULL
probe	NULL
in	NULL
the	NULL
erythroid	NULL
cells	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
shift	NULL
)	NULL
.	NULL

STATS	NULL
antisera	NULL
supershifted	NULL
the	NULL
DNA-protein	NULL
complex	NULL
and	NULL
bound	NULL
to	NULL
the	NULL
labeled	NULL
probe	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
super	NULL
shift	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
STATS	NULL
is	NULL
activated	NULL
by	NULL
erythropoietin	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
STAT3	NULL
nor	NULL
STAT1	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
erythroid	NULL
cells	NULL
stimulated	NULL
by	NULL
erythropoietin	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
upper	NULL
panels	NULL
;	NULL
10	NULL
U/mL	NULL
,	NULL
for	NULL
10	NULL
minutes	NULL
)	NULL
,	NULL
whereas	NULL
IL-6-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
TE-1	NULL
was	NULL
readily	NULL
detected	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
.	NULL
'	NULL

>	NULL
>	NULL
Needless	NULL
to	NULL
say	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
slight	NULL
erythropoietin-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
under	NULL
the	NULL
threshold	NULL
of	NULL
our	NULL
detection	NULL
system	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
observed	NULL
that	NULL
Crk	NULL
]	NULL
,	NULL
a	NULL
39-kD	NULL
SH2/SH3	NULL
adapter	NULL
protein	NULL
,	NULL
becomes	NULL
associated	NULL
with	NULL
STATS	NULL
in	NULL
human	NULL
platelets	NULL
after	NULL
stimulation	NULL
by	NULL
thrombopoietin	NULL
(	NULL
submitted	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
similarity	NULL
between	NULL
thrombopoietin	NULL
and	NULL
erythropoietin	NULL
signal	NULL
transductions	NULL
,	NULL
we	NULL
examined	NULL
phosphotyrosine	NULL
immunoblots	NULL
of	NULL
the	NULL
Crk	NULL
]	NULL
immunoprecipitates	NULL
from	NULL
erythropoietin-treated	NULL
ery-throids	NULL
,	NULL
which	NULL
show	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
protein	NULL
with	NULL
a	NULL
molecular	NULL
weight	NULL
of	NULL
approximately	NULL
95	NULL
to	NULL
100	NULL
kD	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
was	NULL
reactive	NULL
with	NULL
an	NULL
anti-STAT5	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Before	NULL
and	NULL
after	NULL
stimulation	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
Crkl	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
erythroid	NULL
cells	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
specificity	NULL
of	NULL
Crkl-STATS5	NULL
interaction	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
phenylphosphate	NULL
and	NULL
Crk	NULL
]	NULL
immunizing	NULL
peptide	NULL
were	NULL
examined	NULL
.	NULL

More	NULL
STAT	NULL
5	NULL
was	NULL
coimmunoprecipitated	NULL
from	NULL
erythropoietin-stimulated	NULL
cells	NULL
than	NULL
starved	NULL
(	NULL
rest-ing	NULL
)	NULL
cells	NULL
(	NULL
Fig	NULL
5C	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Phenylphosphate	NULL
(	NULL
20	NULL
mmol/L	NULL
)	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
disrupt	NULL
phosphotyrosine-dependent	NULL
protein	NULL
interactions	NULL
and	NULL
was	NULL
added	NULL
after	NULL
the	NULL
lysis	NULL
of	NULL
erythropoietin-stimulated	NULL
cells	NULL
,	NULL
inhibited	NULL
the	NULL
coimmunoprecipitation	NULL
of	NULL
STATS5	NULL
with	NULL
Crk	NULL
]	NULL
(	NULL
Fig	NULL
5C	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
but	NULL
not	NULL
immunoprecipitation	NULL
of	NULL
Crk	NULL
]	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Crk	NULL
]	NULL
immunizing	NULL
peptide	NULL
inhibited	NULL
immunoprecipitation	NULL
of	NULL
Crk	NULL
]	NULL
and	NULL
STAT5	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
Crk	NULL
]	NULL
antisera	NULL
is	NULL
specific	NULL
.	NULL

Because	NULL
phenyl	NULL
phosphate	NULL
inhibited	NULL
the	NULL
coimmunoprecipitation	NULL
of	NULL
STATS	NULL
with	NULL
Crk	NULL
]	NULL
and	NULL
we	NULL
only	NULL
see	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
we	NULL
suspected	NULL
that	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Crk	NULL
]	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
Crk	NULL
]	NULL
to	NULL
the	NULL
phosphorylated	NULL
STAT5	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
binding	NULL
of	NULL
STATS	NULL
to	NULL
bacterially	NULL
expressed	NULL
GST-Crkl-SH2	NULL
protein	NULL
(	NULL
Fig	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

446	NULL
ODA	NULL
ET	NULL
AL	NULL
A	NULL
M.W	NULL
B	NULL
R	NULL
1	NULL
5	NULL
10	NULL
30	NULL
(	NULL
min	NULL
)	NULL
mae	NULL
200	NULL
IP	NULL
_	NULL
:	NULL
Anti-Jak2	NULL
Probe	NULL
:	NULL
Anti-Ptyr	NULL
Jak2	NULL
-	NULL
Â»	NULL
m	NULL
~-	NULL
97.4	NULL
R	NULL
1	NULL
5	NULL
10	NULL
30	NULL
(	NULL
min	NULL
)	NULL
Jak2	NULL
--	NULL
*	NULL
Â»	NULL
-	NULL
69	NULL
IP	NULL
_	NULL
:	NULL
'Anti-Jak2	NULL
Probe	NULL
:	NULL
Anti-Jak2	NULL
C	NULL
0	NULL
0.5	NULL
2	NULL
5	NULL
(	NULL
IU/ml	NULL
)	NULL
Jak2	NULL
-	NULL
Â»	NULL
IP	NULL
:	NULL
'Anti-Jak2	NULL
Probe	NULL
:	NULL
Anti-Ptyr	NULL
IP	NULL
__	NULL
:	NULL
Anti-Jak2	NULL
Probe	NULL
:	NULL
Anti-Ptyr	NULL
EPO	NULL
_	NULL
-	NULL
+	NULL
Jak	NULL
2	NULL
-	NULL
Â»	NULL
-	NULL
Â«	NULL
Â»	NULL
Probe	NULL
:	NULL
Anti-Jak2	NULL
0	NULL
0.5	NULL
2	NULL
5	NULL
(	NULL
IU/ml	NULL
)	NULL
Jak2	NULL
-	NULL
Â»	NULL
IP	NULL
'Anti-Jak2	NULL
IP	NULL
'Anti-Jak2	NULL
Probe	NULL
:	NULL
Anti-Jak2	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
in	NULL
human	NULL
erythroid	NULL
cells	NULL
stimulated	NULL
by	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
.	NULL

Day-8	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/	NULL
mL	NULL
)	NULL
.	NULL

Jak2	NULL
was	NULL
immunoprecipitated	NULL
w	NULL
ith	NULL
specific	NULL
Jak2	NULL
antisera	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
resuspended	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
was	NULL
detected	NULL
by	NULL
4G10	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

(	NULL
A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
The	NULL
same	NULL
nylon	NULL
membrane	NULL
used	NULL
in	NULL
A	NULL
was	NULL
stripped	NULL
of	NULL
the	NULL
antibody	NULL
and	NULL
reprobed	NULL
for	NULL
Jak2	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
NBT/	NULL
BCIP	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
B	NULL
,	NULL
upper	NULL
and	NULL
lower	NULL
panels	NULL
)	NULL
The	NULL
time	NULL
course	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
was	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
erythroid	NULL
cells	NULL
.	NULL

Lanes	NULL
2	NULL
to	NULL
5	NULL
,	NULL
1	NULL
minute	NULL
,	NULL
5	NULL
minutes	NULL
,	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
30	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
.	NULL

(	NULL
B	NULL
,	NULL
upper	NULL
and	NULL
lower	NULL
panels	NULL
)	NULL
The	NULL
time	NULL
course	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
.	NULL

Day-8	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
was	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
,	NULL
upper	NULL
and	NULL
lower	NULL
panels	NULL
)	NULL
The	NULL
dose	NULL
response	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
.	NULL

Day-8	NULL
cells	NULL
were	NULL
stimulated	NULL
w	NULL
ith	NULL
different	NULL
concentrations	NULL
of	NULL
erythropoietin	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
was	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

Lysates	NULL
from	NULL
starved	NULL
(	NULL
-	NULL
)	NULL
erythroid	NULL
cells	NULL
or	NULL
cells	NULL
stimulated	NULL
DISCUSSION	NULL
with	NULL
10	NULL
U/mL	NULL
of	NULL
erythropoietin	NULL
for	NULL
10	NULL
minutes	NULL
(	NULL
+	NULL
)	NULL
were	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
erythropoietin-signaling	NULL
in	NULL
human	NULL
incubated	NULL
with	NULL
GST-Crkl-ST2	NULL
.	NULL

The	NULL
SH2	NULL
domain	NULL
showed	NULL
only	NULL
a	NULL
__	NULL
erythroid	NULL
precursors	NULL
expanded	NULL
in	NULL
vitro	NULL
.	NULL

This	NULL
corroborates	NULL
the	NULL
trace	NULL
amount	NULL
of	NULL
binding	NULL
to	NULL
STATS	NULL
from	NULL
starved	NULL
cells	NULL
with	NULL
a	NULL
recent	NULL
study	NULL
of	NULL
Dai	NULL
et	NULL
al	NULL
``	NULL
``	NULL
and	NULL
indicates	NULL
that	NULL
these	NULL
studies	NULL
are	NULL
significant	NULL
increase	NULL
using	NULL
lysates	NULL
from	NULL
erythroid	NULL
cells	NULL
.	NULL

feasible	NULL
.	NULL

Because	NULL
these	NULL
cells	NULL
,	NULL
unlike	NULL
murine	NULL
factor-dependent	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SIGNALING	NULL
IN	NULL
HUMAN	NULL
ERYTHROID	NULL
CELLS	NULL
MW	NULL
.	NULL

EPO	NULL
-	NULL
__+	NULL
-o	NULL
+	NULL
(	NULL
kB	NULL
)	NULL
STATSA	NULL
_	NULL
,	NULL
Silene	NULL
ame	NULL
-	NULL
97.4	NULL
STATSB	NULL
~-	NULL
69	NULL
L___J	NULL
ba-	NULL
]	NULL
IP	NULL
:	NULL
Anti-STATS5SA	NULL
Anti-STATS5B	NULL
Probe	NULL
:	NULL
Anti-Ptyr	NULL
46	NULL
EPO	NULL
--	NULL
+	NULL
-o	NULL
+	NULL
STATSA	NULL
-p	NULL
tip	NULL
CD	NULL
ap	NULL
DD	NULL
STATSB	NULL
L_	NULL
]	NULL
L_	NULL
]	NULL
IP	NULL
:	NULL
Anti-STATS5A	NULL
Anti-STATSB	NULL
Probe	NULL
:	NULL
Anti-STATS	NULL
(	NULL
MoAb	NULL
)	NULL
Fig	NULL
2	NULL
.	NULL

(	NULL
upper	NULL
panel	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
in	NULL
the	NULL
erythroid	NULL
day-8	NULL
cells	NULL
stimulated	NULL
by	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
erythroid	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
.	NULL

STATS	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
STATSA	NULL
or	NULL
STATSB	NULL
antisera	NULL
as	NULL
indicated	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
resuspended	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
was	NULL
detected	NULL
by	NULL
4G10	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

(	NULL
lower	NULL
panel	NULL
)	NULL
The	NULL
same	NULL
nylon	NULL
mem	NULL
brane	NULL
was	NULL
stripped	NULL
of	NULL
the	NULL
antibody	NULL
and	NULL
reprobed	NULL
for	NULL
STATS	NULL
with	NULL
an	NULL
anti-STAT5	NULL
monoclonal	NULL
antibody	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

cell	NULL
lines	NULL
genetically	NULL
engineered	NULL
to	NULL
express	NULL
erythropoietin	NULL
receptors	NULL
or	NULL
murine	NULL
and	NULL
human	NULL
leukemic	NULL
cell	NULL
lines	NULL
,	NULL
regularly	NULL
undergo	NULL
full	NULL
terminal	NULL
differentiation	NULL
and	NULL
become	NULL
reticulocytes	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
these	NULL
studies	NULL
are	NULL
more	NULL
likely	NULL
to	NULL
be	NULL
reflective	NULL
of	NULL
in	NULL
vivo	NULL
situations	NULL
,	NULL
although	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
artifacts	NULL
arising	NULL
from	NULL
in	NULL
vitro	NULL
culture	NULL
still	NULL
can	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

When	NULL
Drachman	NULL
et	NULL
al	NULL
examined	NULL
murine	NULL
mature	NULL
megakaryocytes	NULL
and	NULL
established	NULL
cell	NULL
lines	NULL
for	NULL
proximate	NULL
signal	NULL
transduction	NULL
triggered	NULL
by	NULL
throm-bopoietin	NULL
,	NULL
they	NULL
found	NULL
that	NULL
there	NULL
were	NULL
significant	NULL
differences	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
results	NULL
of	NULL
the	NULL
studies	NULL
using	NULL
the	NULL
established	NULL
cell	NULL
lines	NULL
may	NULL
not	NULL
readily	NULL
be	NULL
extended	NULL
to	NULL
primary	NULL
cells	NULL
.	NULL
``	NULL

These	NULL
considerations	NULL
led	NULL
us	NULL
to	NULL
examine	NULL
primary	NULL
cultured	NULL
human	NULL
erythroid	NULL
precursor	NULL
cells	NULL
for	NULL
early	NULL
signaling	NULL
induced	NULL
by	NULL
erythropoietin	NULL
.	NULL

We	NULL
found	NULL
that	NULL
Jak2	NULL
became	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
a	NULL
time-	NULL
and	NULL
dose-dependent	NULL
fashion	NULL
in	NULL
human	NULL
erythroid	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
.	NULL
``	NULL

''	NULL
``	NULL
Erythropoietin-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
STAT5A	NULL
and	NULL
STAT5B	NULL
in	NULL
human	NULL
erythroid	NULL
cells	NULL
is	NULL
interesting	NULL
,	NULL
because	NULL
only	NULL
STAT5B	NULL
became	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
chicken	NULL
erythroid	NULL
cells	NULL
.	NULL
``	NULL

We	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
in	NULL
erythropoietin-stimulated	NULL
human	NULL
erythroid	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
Penta	NULL
and	NULL
Sawyer	NULL
!	NULL
``	NULL

found	NULL
that	NULL
447	NULL
erythropoietin-induced	NULL
STAT1	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
its	NULL
activation	NULL
in	NULL
murine	NULL
erythroid	NULL
cells	NULL
.	NULL

Further	NULL
,	NULL
in	NULL
rat	NULL
erythroid	NULL
cells	NULL
from	NULL
fetal	NULL
liver	NULL
,	NULL
STAT3	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
on	NULL
stimulation	NULL
with	NULL
erythropoietin	NULL
.	NULL

'Â©	NULL
Thus	NULL
,	NULL
these	NULL
and	NULL
our	NULL
current	NULL
data	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
species-specific	NULL
differences	NULL
in	NULL
signaling	NULL
by	NULL
erythropoietin	NULL
,	NULL
although	NULL
it	NULL
is	NULL
formally	NULL
possible	NULL
that	NULL
different	NULL
sensitivities	NULL
used	NULL
in	NULL
detection	NULL
of	NULL
STATS	NULL
activation	NULL
may	NULL
have	NULL
contributed	NULL
to	NULL
the	NULL
differences	NULL
.	NULL

Further	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
erythropoietin	NULL
and	NULL
thrombopoietin	NULL
may	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
different	NULL
sets	NULL
of	NULL
STATs	NULL
in	NULL
human	NULL
primary	NULL
cells	NULL
in	NULL
spite	NULL
of	NULL
their	NULL
similarity	NULL
in	NULL
amino	NULL
acid	NULL
sequence	NULL
,	NULL
'	NULL
>	NULL
>	NULL
5	NULL
>	NULL
``	NULL
although	NULL
such	NULL
differences	NULL
may	NULL
be	NULL
obscured	NULL
in	NULL
the	NULL
studies	NULL
that	NULL
used	NULL
established	NULL
cell	NULL
lines	NULL
.	NULL

*	NULL
``	NULL
``	NULL
``	NULL
8	NULL
We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
thrombopoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
and	NULL
STATS5	NULL
in	NULL
thrombopoietin-stimulated	NULL
human	NULL
platelets	NULL
.	NULL
``	NULL

Drachman	NULL
et	NULL
al	NULL
reported	NULL
that	NULL
the	NULL
same	NULL
set	NULL
of	NULL
STATs	NULL
was	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
activated	NULL
in	NULL
thrombopoietin-stimulated	NULL
murine	NULL
mega-karyocytes	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
differences	NULL
in	NULL
activated	NULL
STAT	NULL
's	NULL
by	NULL
erythropoietin	NULL
and	NULL
thrombopoietin	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
lineage-specific	NULL
developments	NULL
of	NULL
both	NULL
erythrocytic	NULL
and	NULL
megakaryocytic	NULL
precursors	NULL
.	NULL

The	NULL
differences	NULL
between	NULL
the	NULL
studies	NULL
that	NULL
used	NULL
primary	NULL
erythroids	NULL
and	NULL
those	NULL
that	NULL
used	NULL
cell	NULL
lines	NULL
are	NULL
not	NULL
limited	NULL
to	NULL
STAT	NULL
proteins	NULL
.	NULL

Barber	NULL
et	NULL
al	NULL
have	NULL
shown	NULL
that	NULL
Crk	NULL
]	NULL
becomes	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
associated	NULL
with	NULL
c-Cbl	NULL
on	NULL
stimulation	NULL
by	NULL
erythropoietin	NULL
.	NULL
``	NULL

''	NULL
However	NULL
,	NULL
we	NULL
found	NULL
that	NULL
in	NULL
primary	NULL
erythroids	NULL
Crk	NULL
]	NULL
becomes	NULL
associated	NULL
with	NULL
a	NULL
95-kD	NULL
tyrosine	NULL
phosphorylated	NULL
protein	NULL
,	NULL
which	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
STAT	NULL
5	NULL
.	NULL

This	NULL
coimmunoprecipitation	NULL
of	NULL
Crk	NULL
]	NULL
and	NULL
STATS	NULL
is	NULL
not	NULL
likely	NULL
caused	NULL
by	NULL
the	NULL
cross	NULL
reactivity	NULL
of	NULL
Crk	NULL
]	NULL
antisera	NULL
with	NULL
STATS	NULL
because	NULL
of	NULL
the	NULL
following	NULL
three	NULL
reasons	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
:	NULL
(	NULL
1	NULL
)	NULL
Crk	NULL
]	NULL
antisera	NULL
coimmunoprecipitated	NULL
STAT5	NULL
mostly	NULL
after	NULL
stimulation	NULL
of	NULL
cells	NULL
with	NULL
erythropoietin	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
if	NULL
this	NULL
is	NULL
a	NULL
cross	NULL
reactivity	NULL
,	NULL
the	NULL
Crk	NULL
]	NULL
antisera	NULL
+	NULL
+\	NULL
|	NULL
EPO	NULL
-	NULL
+	NULL
eSTAT5S	NULL
_	NULL
-	NULL
-	NULL
&	NULL
Super	NULL
Shift	NULL
#	NULL
--	NULL
-	NULL
Shift	NULL
Fig	NULL
3	NULL
.	NULL

Erythropoietin	NULL
activates	NULL
STATS	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Growth	NULL
factor-deprived	NULL
day-8	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
U/mL	NULL
erythropoietin	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
subject	NULL
to	NULL
EMSA	NULL
by	NULL
using	NULL
a	NULL
B-casein	NULL
probe	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
erythropoietin-stimulated	NULL
cells	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
the	NULL
same	NULL
as	NULL
in	NULL
lane	NULL
2	NULL
,	NULL
except	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
STATS	NULL
antisera	NULL
before	NULL
EMSA	NULL
.	NULL

Shift	NULL
indicates	NULL
probe	NULL
complex	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
antibodies	NULL
.	NULL

Super	NULL
Shift	NULL
indicates	NULL
the	NULL
supershifted	NULL
band	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
STATS	NULL
antisera	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

448	NULL
A	NULL
DAY-8	NULL
__	NULL
TFA	NULL
o	NULL
|	NULL
~I	NULL
EPO	NULL
-	NULL
+IL6-	NULL
+0	NULL
MY	NULL
STAT3	NULL
--	NULL
-	NULL
--	NULL
97.4	NULL
~-	NULL
69	NULL
c	NULL
--	NULL
-	NULL
000	NULL
_.	NULL
:	NULL
IP	NULL
_	NULL
:	NULL
Anti-STAT3	NULL
Probe	NULL
:	NULL
Anti-Ptyr	NULL
EPO	NULL
-	NULL
w+ILâ6â	NULL
+	NULL
STAT3	NULL
_.~	NULL
â	NULL
_H~	NULL
IP	NULL
:	NULL
Anti-	NULL
â	NULL
S	NULL
â	NULL
IRAT3	NULL
Probe	NULL
:	NULL
Anti-STAT3	NULL
M.W	NULL
.	NULL

ODA	NULL
ET	NULL
AL	NULL
M.W	NULL
.	NULL

(	NULL
kD	NULL
)	NULL
=-	NULL
97.4	NULL
B	NULL
EPO	NULL
-	NULL
+	NULL
)	NULL
(	NULL
91/84kD	NULL
)	NULL
~-	NULL
69	NULL
HC	NULL
IP	NULL
'Anti-STAT1	NULL
Probe	NULL
:	NULL
Anti-Ptyr	NULL
EPO	NULL
-	NULL
+	NULL
IP	NULL
:	NULL
Anti-STAT1I	NULL
Probe	NULL
:	NULL
Anti-STAT1	NULL
STAT	NULL
(	NULL
91/84kD	NULL
)	NULL
-E	NULL
Fig	NULL
4	NULL
.	NULL

(	NULL
A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
was	NULL
not	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
erythroid	NULL
cells	NULL
stimulated	NULL
with	NULL
erythropoietin	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
erythroid	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
.	NULL

STAT3	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
anti-STAT3	NULL
antisera	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
TF-1	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-6	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
resuspended	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
was	NULL
detected	NULL
by	NULL
4G10	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
resting	NULL
erythroid	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
10	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
erythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
resting	NULL
TF-1	NULL
cells	NULL
,	NULL
lane	NULL
4	NULL
,	NULL
10	NULL
minutes	NULL
after	NULL
exposure	NULL
to	NULL
IL-6	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

(	NULL
lower	NULL
panel	NULL
)	NULL
The	NULL
same	NULL
nylon	NULL
membrane	NULL
was	NULL
stripped	NULL
of	NULL
the	NULL
antibody	NULL
and	NULL
reprobed	NULL
for	NULL
STAT3	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
by	NULL
chemiluminescence	NULL
.	NULL

Lanes	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
upper	NULL
panel	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Anti-STAT1	NULL
was	NULL
used	NULL
instead	NULL
of	NULL
STAT3	NULL
antisera	NULL
.	NULL

must	NULL
recognize	NULL
only	NULL
the	NULL
activated	NULL
form	NULL
of	NULL
STATS	NULL
.	NULL

(	NULL
2	NULL
)	NULL
Crkl	NULL
immunoprecipitation	NULL
and	NULL
STATS5	NULL
coimunoprecipitation	NULL
were	NULL
inhibited	NULL
by	NULL
Crkl	NULL
immunizing	NULL
peptides	NULL
whose	NULL
amino	NULL
acid	NULL
sequence	NULL
is	NULL
not	NULL
found	NULL
in	NULL
STATS	NULL
.	NULL

(	NULL
3	NULL
)	NULL
Phenylphosphate	NULL
inhibited	NULL
coimmunoprecipitation	NULL
of	NULL
STATS	NULL
without	NULL
impairing	NULL
the	NULL
immunoprecipitation	NULL
of	NULL
Crk1	NULL
,	NULL
suggesting	NULL
that	NULL
Crkl-STAT5	NULL
interaction	NULL
may	NULL
be	NULL
dependent	NULL
on	NULL
phosphotyrosine	NULL
on	NULL
STAT5	NULL
,	NULL
because	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Crkl	NULL
.	NULL

The	NULL
last	NULL
supposition	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
results	NULL
of	NULL
in	NULL
vitro	NULL
binding	NULL
of	NULL
GST-Crkl-SH2	NULL
to	NULL
STATS	NULL
from	NULL
stimulated	NULL
erythroid	NULL
cells	NULL
(	NULL
Fig	NULL
5D	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
STATS	NULL
could	NULL
be	NULL
binding	NULL
to	NULL
Crk	NULL
]	NULL
through	NULL
its	NULL
phosphotyrosine-dependent	NULL
interaction	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
Crkl	NULL
.	NULL

However	NULL
,	NULL
STATS	NULL
is	NULL
thought	NULL
to	NULL
dimerize	NULL
when	NULL
tyrosine	NULL
phosphorylated	NULL
through	NULL
its	NULL
SH2	NULL
domain	NULL
binding	NULL
to	NULL
the	NULL
tyrosine	NULL
phosphate	NULL
of	NULL
another	NULL
STAT	NULL
protein	NULL
.	NULL

``	NULL
Â®	NULL
``	NULL
Possible	NULL
explanations	NULL
for	NULL
this	NULL
finding	NULL
include	NULL
the	NULL
fact	NULL
that	NULL
dimerization	NULL
of	NULL
STATS	NULL
is	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
Crk	NULL
]	NULL
or	NULL
that	NULL
erythropoietin	NULL
treatment	NULL
results	NULL
in	NULL
an	NULL
altered	NULL
subcellular	NULL
localization	NULL
of	NULL
Crk	NULL
]	NULL
or	NULL
STAT5	NULL
that	NULL
allows	NULL
these	NULL
proteins	NULL
to	NULL
interact	NULL
.	NULL

Alternatively	NULL
,	NULL
another	NULL
protein	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
mediating	NULL
the	NULL
complex	NULL
formation	NULL
.	NULL

Although	NULL
more	NULL
studies	NULL
are	NULL
necessary	NULL
,	NULL
our	NULL
study	NULL
indicates	NULL
that	NULL
activated	NULL
STATS5	NULL
complex	NULL
is	NULL
not	NULL
simply	NULL
made	NULL
of	NULL
dimerized	NULL
STATS5	NULL
in	NULL
human	NULL
erythroid	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
complex	NULL
may	NULL
include	NULL
Crk	NULL
]	NULL
and	NULL
possible	NULL
other	NULL
proteins	NULL
as	NULL
well	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
results	NULL
of	NULL
the	NULL
studies	NULL
that	NULL
used	NULL
the	NULL
primary	NULL
erythroids	NULL
may	NULL
be	NULL
quite	NULL
different	NULL
from	NULL
those	NULL
obtained	NULL
from	NULL
the	NULL
experiments	NULL
that	NULL
were	NULL
solely	NULL
dependent	NULL
on	NULL
cell	NULL
lines	NULL
,	NULL
giving	NULL
a	NULL
rationale	NULL
for	NULL
further	NULL
examinations	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
of	NULL
primary	NULL
human	NULL
erythroid	NULL
precursors	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
importance	NULL
of	NULL
examinations	NULL
of	NULL
proximal	NULL
signal	NULL
transduction	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
recent	NULL
reports	NULL
,	NULL
suggesting	NULL
that	NULL
abrogation	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
may	NULL
be	NULL
related	NULL
to	NULL
the	NULL
increased	NULL
erythropoiesis	NULL
in	NULL
polycythemic	NULL
pa-tients.334Â°	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SIGNALING	NULL
IN	NULL
HUMAN	NULL
ERYTHROID	NULL
CELLS	NULL
449	NULL
A	NULL
rro	NULL
-	NULL
%	NULL
311ng	NULL
B	NULL
EPO	NULL
-	NULL
+	NULL
==	NULL
200	NULL
STATS	NULL
-	NULL
Â»	NULL
<	NULL
egeme	NULL
97.4	NULL
69	NULL
STATS	NULL
-	NULL
Â»	NULL
IP	NULL
:	NULL
Anti-	NULL
Crk	NULL
]	NULL
|	NULL
Probe	NULL
:	NULL
Anti-	NULL
STATS	NULL
HC	NULL
--	NULL
._	NULL
46	NULL
EPO	NULL
-	NULL
+	NULL
=	NULL
30	NULL
C	NULL
:	NULL
ll	NULL
-O-	NULL
~-	NULL
Gam	NULL
IP	NULL
:	NULL
Anti-	NULL
Crk	NULL
]	NULL
IP	NULL
:	NULL
Anti-	NULL
Crk	NULL
]	NULL
Probe	NULL
:	NULL
Anti-	NULL
Ptyr	NULL
Probe	NULL
:	NULL
Anti-	NULL
Crk	NULL
]	NULL
Resting	NULL
+	NULL
EPO	NULL
=	NULL
c	NULL
:	NULL
D	NULL
+	NULL
M.w	NULL
.	NULL

+	NULL
PP	NULL
-	NULL
+Peptide	NULL
15g	NULL
;	NULL
857131	NULL
)	NULL
97.4	NULL
*	NULL
STATS-	NULL
Â»	NULL
Mae	NULL
STAT	NULL
S5	NULL
-	NULL
Â»	NULL
Probe	NULL
:	NULL
Anti-STATS	NULL
Probe	NULL
:	NULL
Anti-STATS	NULL
f	NULL
o	NULL
GST	NULL
-	NULL
Â»	NULL
@	NULL
@	NULL
P	NULL
o	NULL
ii	NULL
P	NULL
Crk1-SH2	NULL
Probe	NULL
:	NULL
Anti-GST	NULL
Probe	NULL
:	NULL
Anti-Crkl	NULL
Fig	NULL
5	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Crk	NULL
immunoprecipitates	NULL
from	NULL
erythropoietin-stimulated	NULL
erythroid	NULL
cells	NULL
contain	NULL
a	NULL
tyrosine	NULL
phosphorylated	NULL
95-	NULL
to	NULL
100-kD	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
also	NULL
recognized	NULL
by	NULL
a	NULL
STATS	NULL
monoclonal	NULL
antibody	NULL
.	NULL

Erythroid	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
2	NULL
%	NULL
Triton	NULL
X-100	NULL
before	NULL
and	NULL
after	NULL
exposure	NULL
to	NULL
eythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
for	NULL
10	NULL
minutes	NULL
)	NULL
.	NULL

Ork	NULL
!	NULL

was	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
Ork|	NULL
antisera	NULL
.	NULL

The	NULL
Crkl	NULL
immunoprecipitates	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
(	NULL
A	NULL
)	NULL
,	NULL
STATS	NULL
(	NULL
B	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
Crk	NULL
!	NULL

(	NULL
B	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
in	NULL
the	NULL
Crkl	NULL
immunoprecipitates	NULL
were	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Crkl-STAT5	NULL
coiommunoprecipitation	NULL
was	NULL
inhibited	NULL
by	NULL
phenylphosphate	NULL
(	NULL
PP	NULL
,	NULL
20	NULL
mmol/L	NULL
)	NULL
or	NULL
Crkl	NULL
immunizing	NULL
peptide	NULL
(	NULL
20	NULL
g/mL	NULL
)	NULL
.	NULL

Erythroid	NULL
cells	NULL
were	NULL
divided	NULL
equally	NULL
to	NULL
four	NULL
samples	NULL
.	NULL

Three	NULL
samples	NULL
were	NULL
incubated	NULL
wtih	NULL
eythropoietin	NULL
(	NULL
10	NULL
U/mL	NULL
for	NULL
10	NULL
minutes	NULL
)	NULL
.	NULL

Crk	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
Ork	NULL
!	NULL

antisera	NULL
.	NULL

STATS	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
Crkl	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
in	NULL
the	NULL
Crk	NULL
!	NULL

immunoprecipitates	NULL
were	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
(	NULL
A	NULL
)	NULL
and	NULL
(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Bacterially	NULL
expressed	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
(	NULL
GST-Crkl-SH2	NULL
)	NULL
binds	NULL
to	NULL
STATS	NULL
from	NULL
erythropoietin-stimulated	NULL
erythroid	NULL
cells	NULL
.	NULL

Lysates	NULL
from	NULL
starved	NULL
(	NULL
-	NULL
)	NULL
erythroid	NULL
cells	NULL
or	NULL
cells	NULL
stimulated	NULL
with	NULL
10	NULL
U/mL	NULL
of	NULL
erythropoietin	NULL
for	NULL
10	NULL
minutes	NULL
(	NULL
+	NULL
)	NULL
were	NULL
analyzed	NULL
for	NULL
binding	NULL
to	NULL
GST-Crkl-SH2	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
and	NULL
immunoblotted	NULL
with	NULL
STATS	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
GST	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

450	NULL
ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Dr	NULL
C.I	NULL
.	NULL

Civin	NULL
for	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
without	NULL
which	NULL
this	NULL
work	NULL
could	NULL
not	NULL
have	NULL
been	NULL
done	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Drs	NULL
Hiroshi	NULL
Wakao	NULL
and	NULL
Atsushi	NULL
Miyajima	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
thank	NULL
Dr	NULL
S.C.	NULL
Clark	NULL
,	NULL
Dr	NULL
Hiroshi	NULL
Wakao	NULL
,	NULL
Genetics	NULL
Institute	NULL
,	NULL
Kirin	NULL
Brewery	NULL
Co	NULL
,	NULL
and	NULL
Chugai	NULL
Pharmaceutical	NULL
Co	NULL
for	NULL
the	NULL
generous	NULL
gifts	NULL
of	NULL
recombinant	NULL
human	NULL
growth	NULL
factors	NULL
;	NULL
Dr	NULL
Hisamaru	NULL
Hirai	NULL
for	NULL
TE-1	NULL
cells	NULL
;	NULL
and	NULL
Taisho	NULL
Pharmaceutical	NULL
Co	NULL
for	NULL
providing	NULL
chymopapain	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Krantz	NULL
SB	NULL
:	NULL
Erythropoietin	NULL
.	NULL

Blood	NULL
77:419	NULL
,	NULL
1991	NULL
2	NULL
.	NULL

Koury	NULL
MJ	NULL
,	NULL
Bondurant	NULL
MC	NULL
:	NULL
The	NULL
molecular	NULL
mechanism	NULL
of	NULL
erythropoietin	NULL
action	NULL
.	NULL

Eur	NULL
J	NULL
Biochem	NULL
210:649	NULL
,	NULL
1992	NULL
3	NULL
.	NULL

Youssoufian	NULL
H	NULL
,	NULL
Longmore	NULL
G	NULL
,	NULL
Neuman	NULL
D	NULL
,	NULL
Yoshimura	NULL
A	NULL
,	NULL
Lodish	NULL
HF	NULL
:	NULL
Structure	NULL
,	NULL
function	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

Blood	NULL
81:2223	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Sayer	NULL
ST	NULL
,	NULL
Penta	NULL
K	NULL
:	NULL
Erythropoietin	NULL
cell	NULL
biology	NULL
.	NULL

Hematol	NULL
Oncol	NULL
Clin	NULL
North	NULL
Am	NULL
8:895	NULL
,	NULL
1994	NULL
5	NULL
.	NULL

Sui	NULL
X	NULL
,	NULL
Tsuji	NULL
K	NULL
,	NULL
Tajima	NULL
S	NULL
,	NULL
Tanaka	NULL
R	NULL
,	NULL
Muraoka	NULL
K	NULL
,	NULL
Ebihara	NULL
Y	NULL
,	NULL
Ikebuchi	NULL
K	NULL
,	NULL
Yasukawa	NULL
K	NULL
,	NULL
Taga	NULL
T	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Nakahata	NULL
T	NULL
:	NULL
Erythropoi-etin-independent	NULL
erythrocyte	NULL
production	NULL
:	NULL
Signals	NULL
through	NULL
gp130	NULL
and	NULL
c-kit	NULL
dramatically	NULL
promote	NULL
erythropoiesis	NULL
from	NULL
human	NULL
CD34	NULL
*	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
183:837	NULL
,	NULL
1996	NULL
6	NULL
.	NULL

Witthuhn	NULL
BA	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Silvennoinen	NULL
O	NULL
,	NULL
Yi	NULL
T	NULL
,	NULL
Tang	NULL
B	NULL
,	NULL
Miura	NULL
O	NULL
,	NULL
Thle	NULL
JN	NULL
:	NULL
Jak2	NULL
associates	NULL
with	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
and	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
and	NULL
activated	NULL
following	NULL
stimulation	NULL
with	NULL
erythropoietin	NULL
.	NULL

Cell	NULL
74:227	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

Miura	NULL
O	NULL
,	NULL
Nakamura	NULL
N	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Witthuman	NULL
BA	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Aoki	NULL
N	NULL
:	NULL
Erythropoietin	NULL
induces	NULL
association	NULL
of	NULL
the	NULL
Jak2	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
with	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
in	NULL
vivo	NULL
.	NULL

Blood	NULL
84:1501	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Wakao	NULL
H	NULL
,	NULL
Harada	NULL
N	NULL
,	NULL
Kitamura	NULL
T	NULL
,	NULL
Mui	NULL
AL	NULL
,	NULL
Miyajima	NULL
A	NULL
:	NULL
Interleukin	NULL
2	NULL
and	NULL
erythropoietin	NULL
activate	NULL
STATS/MGF	NULL
via	NULL
distinct	NULL
pathways	NULL
.	NULL

EMBO	NULL
J	NULL
14:2527	NULL
,	NULL
1995	NULL
8	NULL
.	NULL

Sawyer	NULL
ST	NULL
,	NULL
Penta	NULL
K	NULL
:	NULL
Association	NULL
of	NULL
Jak2	NULL
and	NULL
STATS	NULL
with	NULL
erythropoietin	NULL
receptors	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:32430	NULL
,	NULL
1996	NULL
9	NULL
.	NULL

Quell	NULL
FW	NULL
,	NULL
Wang	NULL
D	NULL
,	NULL
Nosaka	NULL
T	NULL
,	NULL
Thierfelder	NULL
WE	NULL
,	NULL
Stravopodis	NULL
D	NULL
,	NULL
Weinstein	NULL
Y	NULL
,	NULL
Ihle	NULL
JN	NULL
:	NULL
Erythropoietin	NULL
induces	NULL
activation	NULL
of	NULL
Stat5	NULL
through	NULL
association	NULL
with	NULL
specific	NULL
tyrosines	NULL
on	NULL
the	NULL
receptor	NULL
that	NULL
are	NULL
not	NULL
required	NULL
for	NULL
mitogenic	NULL
response	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:1622	NULL
,	NULL
1996	NULL
10	NULL
.	NULL

Ohashi	NULL
T	NULL
,	NULL
Masuda	NULL
M	NULL
,	NULL
Ruscetti	NULL
SK	NULL
:	NULL
Induction	NULL
of	NULL
sequence-specific	NULL
DNA-binding	NULL
factors	NULL
by	NULL
erythropoietin	NULL
and	NULL
the	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
.	NULL

Blood	NULL
85:1454	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Klingmuller	NULL
U	NULL
,	NULL
Bergelson	NULL
S	NULL
,	NULL
Hsio	NULL
JG	NULL
,	NULL
Lodish	NULL
HF	NULL
:	NULL
Multiple	NULL
tyrosine	NULL
residues	NULL
in	NULL
the	NULL
cytosolic	NULL
domain	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
promote	NULL
activation	NULL
of	NULL
STAT	NULL
5	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:8324	NULL
,	NULL
1997	NULL
12	NULL
.	NULL

Darnell	NULL
J	NULL
Jr	NULL
:	NULL
The	NULL
JAK-STAT	NULL
pathway	NULL
:	NULL
Summary	NULL
of	NULL
initial	NULL
studies	NULL
and	NULL
recent	NULL
advances	NULL
.	NULL

Recent	NULL
Prog	NULL
Horm	NULL
Res	NULL
51:391	NULL
,	NULL
1996	NULL
13	NULL
.	NULL

Thie	NULL
JN	NULL
:	NULL
Janus	NULL
kinases	NULL
in	NULL
cytokine	NULL
signaling	NULL
.	NULL

Philos	NULL
Trans	NULL
R	NULL
Soc	NULL
Lond	NULL
B	NULL
Biol	NULL
Sci	NULL
351:159	NULL
,	NULL
1996	NULL
14	NULL
.	NULL

Penta	NULL
K	NULL
,	NULL
Sawyer	NULL
ST	NULL
:	NULL
Erythropoietin	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
STAT1	NULL
and	NULL
STATS	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:31282	NULL
,	NULL
1995	NULL
15	NULL
.	NULL

Mellitzer	NULL
G	NULL
,	NULL
Wesseley	NULL
O	NULL
,	NULL
Decker	NULL
T	NULL
,	NULL
Meinke	NULL
A	NULL
,	NULL
Hayman	NULL
MJ	NULL
,	NULL
Beug	NULL
H	NULL
:	NULL
Activation	NULL
of	NULL
STATS5b	NULL
in	NULL
erythroid	NULL
progenitors	NULL
correlates	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
ErbB	NULL
to	NULL
induce	NULL
sustained	NULL
cell	NULL
proliferation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:9600	NULL
,	NULL
1996	NULL
16	NULL
.	NULL

Chreitien	NULL
S	NULL
,	NULL
Verdier	NULL
F	NULL
,	NULL
Varlet	NULL
P	NULL
,	NULL
Gobert	NULL
S	NULL
,	NULL
Devermy	NULL
E	NULL
,	NULL
Billat	NULL
C	NULL
,	NULL
Gisselbrecht	NULL
,	NULL
Mayyeux	NULL
P	NULL
,	NULL
Lacombe	NULL
C	NULL
:	NULL
Identification	NULL
of	NULL
STAT	NULL
proteins	NULL
activated	NULL
by	NULL
erythropoietin	NULL
in	NULL
normal	NULL
erythroid	NULL
progenitors	NULL
and	NULL
in	NULL
murine	NULL
and	NULL
human	NULL
erythroleukemia	NULL
.	NULL

Blood	NULL
88:54a	NULL
,	NULL
1996	NULL
(	NULL
abstr	NULL
,	NULL
suppl	NULL
)	NULL
17	NULL
.	NULL

Miyakawa	NULL
Y	NULL
,	NULL
Oda	NULL
A	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
Kato	NULL
T	NULL
,	NULL
Miyazaki	NULL
H	NULL
,	NULL
Handa	NULL
M	NULL
,	NULL
Ikeda	NULL
Y	NULL
:	NULL
Recombinant	NULL
thrombopoietin	NULL
induces	NULL
rapid	NULL
protein	NULL
tyrosine	NULL
ODA	NULL
ET	NULL
AL	NULL
phosphorylation	NULL
of	NULL
Janus	NULL
kinase	NULL
2	NULL
and	NULL
Shc	NULL
in	NULL
human	NULL
blood	NULL
platelets	NULL
.	NULL

Blood	NULL
86:23	NULL
,	NULL
1995	NULL
18	NULL
.	NULL

Miyakawa	NULL
Y	NULL
,	NULL
Oda	NULL
A	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
Miyazaki	NULL
H	NULL
,	NULL
Handa	NULL
M	NULL
,	NULL
Ohashi	NULL
H	NULL
,	NULL
Ikeda	NULL
Y	NULL
:	NULL
Thrombopoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat5	NULL
in	NULL
human	NULL
blood	NULL
platelets	NULL
.	NULL

Blood	NULL
87:439	NULL
,	NULL
1996	NULL
19	NULL
.	NULL

Oda	NULL
A	NULL
,	NULL
Miyakawa	NULL
Y	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
Ishida	NULL
A	NULL
,	NULL
Ozaki	NULL
K	NULL
,	NULL
Ohashi	NULL
H	NULL
,	NULL
Wakui	NULL
M	NULL
,	NULL
Handa	NULL
M	NULL
,	NULL
Watanabe	NULL
K	NULL
,	NULL
Okamoto	NULL
S	NULL
,	NULL
Ikeda	NULL
Y	NULL
:	NULL
Crk	NULL
]	NULL
is	NULL
constitutively	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
platelets	NULL
from	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
patients	NULL
and	NULL
inducibly	NULL
phosphorylated	NULL
in	NULL
normal	NULL
platelets	NULL
stimulated	NULL
by	NULL
thrombopoicetin	NULL
.	NULL

Blood	NULL
88:4304	NULL
,	NULL
1996	NULL
20	NULL
.	NULL

Wakao	NULL
H	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Mammary	NULL
gland	NULL
factor	NULL
(	NULL
MGF	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
regulated	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
and	NULL
confers	NULL
the	NULL
prolactin	NULL
response	NULL
.	NULL

EMBO	NULL
J	NULL
13:2182	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

Sato	NULL
N	NULL
,	NULL
Sawada	NULL
K	NULL
,	NULL
Takahashi	NULL
TA	NULL
,	NULL
Mogi	NULL
Y	NULL
,	NULL
Asano	NULL
S	NULL
,	NULL
Koike	NULL
T	NULL
,	NULL
Sekiguchi	NULL
S	NULL
:	NULL
A	NULL
time	NULL
course	NULL
study	NULL
for	NULL
optimal	NULL
harvest	NULL
of	NULL
peripheral	NULL
blood	NULL
progenitor	NULL
cells	NULL
by	NULL
granulocyte	NULL
colony	NULL
stimulating	NULL
factor	NULL
in	NULL
healthy	NULL
volunteers	NULL
.	NULL

Exp	NULL
Heamatol	NULL
22:973	NULL
,	NULL
1994	NULL
22	NULL
.	NULL

Sawada	NULL
K	NULL
,	NULL
Krantz	NULL
SB	NULL
,	NULL
Dai	NULL
CH	NULL
,	NULL
Koury	NULL
ST	NULL
,	NULL
Horn	NULL
ST	NULL
,	NULL
Glick	NULL
AD	NULL
,	NULL
Civin	NULL
CI	NULL
:	NULL
Purification	NULL
of	NULL
human	NULL
blood	NULL
burst	NULL
forming	NULL
units	NULL
erythroid	NULL
and	NULL
demonstration	NULL
of	NULL
the	NULL
evolution	NULL
of	NULL
erythropoietin	NULL
receptors	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
142:219	NULL
,	NULL
1993	NULL
23	NULL
.	NULL

Yamaguchi	NULL
M	NULL
,	NULL
Sawada	NULL
K	NULL
,	NULL
Sato	NULL
N	NULL
,	NULL
Koizumi	NULL
K	NULL
,	NULL
Sekiguchi	NULL
S	NULL
,	NULL
Koike	NULL
T	NULL
:	NULL
A	NULL
rapid	NULL
nylon	NULL
fiber	NULL
syringe	NULL
system	NULL
to	NULL
deplete	NULL
CD14	NULL
*	NULL
cells	NULL
for	NULL
positive	NULL
selection	NULL
of	NULL
human	NULL
blood	NULL
CD34+*	NULL
cells	NULL
.	NULL

Use	NULL
of	NULL
immunomag-netic	NULL
microspheres	NULL
.	NULL

Bone	NULL
Marrow	NULL
Transplant	NULL
19:373	NULL
,	NULL
1997	NULL
24	NULL
.	NULL

Sawada	NULL
K	NULL
,	NULL
Krantz	NULL
SB	NULL
,	NULL
Dai	NULL
CH	NULL
,	NULL
Sato	NULL
N	NULL
,	NULL
Ieko	NULL
M	NULL
,	NULL
Sakurama	NULL
S	NULL
,	NULL
Yasukouchi	NULL
T	NULL
,	NULL
Nakagawa	NULL
S	NULL
:	NULL
Transitional	NULL
change	NULL
of	NULL
colony	NULL
stimulating	NULL
factor	NULL
requirements	NULL
for	NULL
erythroid	NULL
progenitors	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
149:1	NULL
,	NULL
1991	NULL
25	NULL
.	NULL

Sawada	NULL
K	NULL
,	NULL
Krantz	NULL
SB	NULL
,	NULL
Dessypris	NULL
EN	NULL
,	NULL
Koury	NULL
ST	NULL
,	NULL
Sawyer	NULL
ST	NULL
:	NULL
Human	NULL
colony	NULL
forming	NULL
units	NULL
erythroid	NULL
do	NULL
not	NULL
require	NULL
accessory	NULL
cells	NULL
,	NULL
but	NULL
do	NULL
require	NULL
direct	NULL
interaction	NULL
with	NULL
insulin	NULL
like	NULL
growth	NULL
factor	NULL
I	NULL
and/or	NULL
insulin	NULL
for	NULL
erythroid	NULL
development	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
83:1701	NULL
,	NULL
1989	NULL
26	NULL
.	NULL

McLeod	NULL
DL	NULL
,	NULL
Shreeve	NULL
MM	NULL
,	NULL
Axelrad	NULL
AA	NULL
:	NULL
Improved	NULL
plasma	NULL
culture	NULL
system	NULL
for	NULL
production	NULL
of	NULL
erythrocytic	NULL
colonies	NULL
in	NULL
vitro	NULL
.	NULL

Quantitative	NULL
assay	NULL
method	NULL
for	NULL
CFU-E	NULL
.	NULL

Blood	NULL
44:517	NULL
,	NULL
1974	NULL
27	NULL
.	NULL

Sawada	NULL
K	NULL
,	NULL
Krantz	NULL
SB	NULL
,	NULL
Kans	NULL
JS	NULL
,	NULL
Dessypris	NULL
EN	NULL
,	NULL
Sawyer	NULL
S	NULL
,	NULL
Glick	NULL
AD	NULL
,	NULL
Civin	NULL
CI	NULL
:	NULL
Purification	NULL
of	NULL
human	NULL
erythroid	NULL
colony	NULL
forming	NULL
units	NULL
and	NULL
demonstration	NULL
of	NULL
specific	NULL
binding	NULL
of	NULL
erythropoietin	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
80:357	NULL
,	NULL
1987	NULL
28	NULL
.	NULL

Sawada	NULL
K	NULL
,	NULL
Sato	NULL
N	NULL
,	NULL
Notoya	NULL
A	NULL
,	NULL
Tarumi	NULL
T	NULL
,	NULL
Hirayama	NULL
S	NULL
,	NULL
Takano	NULL
H	NULL
,	NULL
Koizumi	NULL
K	NULL
,	NULL
Yasukouchi	NULL
T	NULL
,	NULL
Yamaguchi	NULL
M	NULL
,	NULL
Koike	NULL
T	NULL
:	NULL
Proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
myelodysplastic	NULL
CD34	NULL
*	NULL
cells	NULL
:	NULL
Phenotypic	NULL
subpopula-tions	NULL
of	NULL
marrow	NULL
CD34	NULL
*	NULL
cells	NULL
.	NULL

Blood	NULL
85:194	NULL
,	NULL
1995	NULL
29	NULL
.	NULL

Laemmli	NULL
UK	NULL
:	NULL
Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
227:680	NULL
,	NULL
1970	NULL
30	NULL
.	NULL

Kitamura	NULL
T	NULL
,	NULL
Tange	NULL
T	NULL
,	NULL
Terasawa	NULL
T	NULL
,	NULL
Chiba	NULL
S	NULL
,	NULL
Kuwaki	NULL
T	NULL
,	NULL
Miyagawa	NULL
K	NULL
,	NULL
Piao	NULL
YF	NULL
,	NULL
Miyazono	NULL
K	NULL
,	NULL
Urabe	NULL
A	NULL
,	NULL
Takaku	NULL
F	NULL
:	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
unique	NULL
human	NULL
cell	NULL
line	NULL
that	NULL
proliferates	NULL
dependent	NULL
on	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
or	NULL
erythropoietin	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
140:323	NULL
,	NULL
1989	NULL
31	NULL
.	NULL

Oda	NULL
T	NULL
,	NULL
Heaney	NULL
C	NULL
,	NULL
Hagopian	NULL
JR	NULL
,	NULL
Okuda	NULL
K	NULL
,	NULL
Griffin	NULL
JD	NULL
,	NULL
Druker	NULL
BJ	NULL
:	NULL
Crkl	NULL
is	NULL
the	NULL
major	NULL
tyrosine-phosphorylated	NULL
protein	NULL
in	NULL
neutrophils	NULL
from	NULL
patients	NULL
with	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:22925	NULL
,	NULL
1994	NULL
32	NULL
.	NULL

Heaney	NULL
C	NULL
,	NULL
Kolibaba	NULL
K	NULL
,	NULL
Bhat	NULL
A	NULL
,	NULL
Oda	NULL
T	NULL
,	NULL
Ohno	NULL
S	NULL
,	NULL
Fanning	NULL
S	NULL
,	NULL
Druker	NULL
BJ	NULL
:	NULL
Direct	NULL
binding	NULL
of	NULL
CRKL	NULL
to	NULL
BCR-ABL	NULL
is	NULL
not	NULL
required	NULL
for	NULL
BCR-ABL	NULL
transformation	NULL
.	NULL

Blood	NULL
89:297	NULL
,	NULL
1997	NULL
33	NULL
.	NULL

Dai	NULL
CH	NULL
,	NULL
Krantz	NULL
SB	NULL
,	NULL
Sawyer	NULL
ST	NULL
:	NULL
Polycythemia	NULL
vera	NULL
.	NULL

V.	NULL
Enhanced	NULL
proliferation	NULL
and	NULL
phosphorylation	NULL
due	NULL
to	NULL
vanadate	NULL
are	NULL
diminished	NULL
in	NULL
polycythemia	NULL
vera	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
:	NULL
A	NULL
possible	NULL
defect	NULL
of	NULL
phosphatase	NULL
activity	NULL
in	NULL
polycythemia	NULL
vera	NULL
.	NULL

Blood	NULL
89:3574	NULL
,	NULL
1997	NULL
34	NULL
.	NULL

Drachman	NULL
JG	NULL
,	NULL
Sabath	NULL
DF	NULL
,	NULL
Fox	NULL
NE	NULL
,	NULL
Kaushansy	NULL
K	NULL
:	NULL
Thrombopoietin	NULL
signal	NULL
transduction	NULL
in	NULL
purified	NULL
murine	NULL
megakaryocytes	NULL
.	NULL

Blood	NULL
89:483	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

SIGNALING	NULL
IN	NULL
HUMAN	NULL
ERYTHROID	NULL
CELLS	NULL
35	NULL
.	NULL

Kaushansky	NULL
K	NULL
:	NULL
Thrombopoietin	NULL
:	NULL
The	NULL
primary	NULL
regulator	NULL
of	NULL
platelet	NULL
production	NULL
.	NULL

Blood	NULL
86:419	NULL
,	NULL
1995	NULL
36	NULL
.	NULL

Nagata	NULL
Y	NULL
,	NULL
Todokoro	NULL
K	NULL
:	NULL
Interleukin	NULL
3	NULL
activates	NULL
not	NULL
only	NULL
Jak2	NULL
and	NULL
STATS	NULL
,	NULL
but	NULL
also	NULL
Tyk2	NULL
,	NULL
STAT1	NULL
,	NULL
and	NULL
STAT3	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
221:785	NULL
,	NULL
1996	NULL
37	NULL
.	NULL

Barber	NULL
DL	NULL
,	NULL
Mason	NULL
JM	NULL
,	NULL
Fukazawa	NULL
T	NULL
,	NULL
Reedquist	NULL
KA	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
Band	NULL
H	NULL
,	NULL
D'Andrea	NULL
AD	NULL
:	NULL
Erythropoietin	NULL
and	NULL
interleukin-3	NULL
activate	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CBL	NULL
and	NULL
association	NULL
with	NULL
CRK	NULL
adaptor	NULL
proteins	NULL
.	NULL

Blood	NULL
89:3166	NULL
,	NULL
1997	NULL
451	NULL
38	NULL
.	NULL

Schindler	NULL
C	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
Transcriptional	NULL
responses	NULL
to	NULL
poly-peptide	NULL
ligands	NULL
:	NULL
The	NULL
JAK-STAT	NULL
pathway	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
64:621	NULL
,	NULL
1995	NULL
39	NULL
.	NULL

Ihle	NULL
JN	NULL
:	NULL
Signaling	NULL
by	NULL
the	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
in	NULL
normal	NULL
and	NULL
transformed	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Adv	NULL
Cancer	NULL
Res	NULL
68:23	NULL
,	NULL
1996	NULL
40	NULL
.	NULL

Sui	NULL
X	NULL
,	NULL
Krantz	NULL
SB	NULL
,	NULL
Zhao	NULL
Z	NULL
:	NULL
Identification	NULL
of	NULL
increased	NULL
tyrosine	NULL
phosphatase	NULL
activity	NULL
in	NULL
polycythemia	NULL
vera	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
.	NULL

Blood	NULL
90:651	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
==	NULL
--	NULL
Erythropoietin	NULL
Induces	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
Jak2	NULL
,	NULL
STAT5SA	NULL
,	NULL
and	NULL
STAT5B	NULL
in	NULL
Primary	NULL
Cultured	NULL
Human	NULL
Erythroid	NULL
Precursors	NULL
Atsushi	NULL
Oda	NULL
,	NULL
Kenichi	NULL
Sawada	NULL
,	NULL
Brian	NULL
J.	NULL
Druker	NULL
,	NULL
Katsutoshi	NULL
Ozaki	NULL
,	NULL
Hina	NULL
Takano	NULL
,	NULL
Kazuki	NULL
Koizumi	NULL
,	NULL
Yoshikazu	NULL
Fukada	NULL
,	NULL
Makoto	NULL
Handa	NULL
,	NULL
Takao	NULL
Koike	NULL
and	NULL
Yasuo	NULL
Ikeda	NULL
4	NULL
QM	NULL
â	NULL
Caw	NULL
,	NULL
.	NULL

,	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

2	NULL
YOtowÂ®	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/2/443.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

